Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women's health and quality of life
Ocon Healthcare has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Ocon Healthcare's investors include Israel Innovation Authority, Pontifax, Astia Angels, Rhia Ventures, RH Capital.
Ocon Healthcare is headquartered in Modi'in, Israel.
Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women's health and quality of life
Ocon Healthcare is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ocon Healthcare — Funding & Investors." VCBacked, June 24, 2024, https://www.vcbacked.co/company/ocon-healthcare. Accessed July 27, 2026.
VCBacked. (2024). Ocon Healthcare — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/ocon-healthcare
{{cite web |title=Ocon Healthcare — Funding & Investors |url=https://www.vcbacked.co/company/ocon-healthcare |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated